Logo image of AADI

AADI BIOSCIENCE INC (AADI) Stock Analyst Ratings

NASDAQ:AADI - Nasdaq - US00032Q1040 - Common Stock - Currency: USD

2.05  -0.05 (-2.38%)

After market: 2.06 +0.01 (+0.49%)

Buy % Consensus

48

ChartMill assigns a Buy % Consensus number of 48% to AADI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.06. This target is 49.27% above the current price.
AADI was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about AADI.
In the previous month the buy percentage consensus was at a similar level.
AADI was analyzed by 8 analysts. More opinions would make the average more meaningful.
AADI Historical Analyst RatingsAADI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -82 -74 -66 -58 -50 -42 -34 -26 -18 -10 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.053.033.063.063.15 - 47.80% 49.27% 49.27% 53.66%
AADI Current Analyst RatingAADI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2024-08-27 Piper Sandler Downgrade Overweight -> Neutral
2024-08-21 TD Cowen Downgrade Buy -> Hold
2024-08-21 HC Wainwright & Co. Reiterate Neutral
2024-05-14 HC Wainwright & Co. Reiterate Neutral
2023-12-15 Piper Sandler Maintains Overweight -> Overweight
2023-12-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-11-13 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-10 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-29 HC Wainwright & Co. Maintains Buy
2022-04-11 HC Wainwright & Co. Maintains Buy
2022-01-11 Jefferies Initiate Buy
2021-11-24 HC Wainwright & Co. Maintains Buy
2021-10-01 Cowen & Co. Initiate Outperform
2021-09-14 Ladenburg Thalmann Initiate Buy
2021-09-08 Piper Sandler Initiate Overweight
2021-08-30 HC Wainwright & Co. Maintains Buy